Jingdong Health listed in Hong Kong for two days, the share price continued to soar. December 9, Jingdong Health shares share price closed at 112.20 Hong Kong dollars, with a total share capital of 3.127 billion shares, the market value of more than 350 billion Hong Kong dollars, to become the Hong Kong Stock Exchange in the same field of the highest market value of enterprises.
However, this morning, Jingdong Health share price began to turn down, the share price once fell more than 5%. As of press time, Jingdong Health shares narrowed to 2.23% down at HK$109.7, with a current market capitalization of HK$343.041 billion.
1.png
According to the prospectus, in the first three quarters of 2020, Jingdong Health’s revenue has reached 13.2 billion yuan. Among them, the retail pharmacy business accounted for 87.6%, which is the main source of revenue for the company.
It is worth noting that although the retail pharmacy business accounts for a relatively large share of the total revenue, the company’s revenue does not rely mainly on “selling drugs”, but rather the sales of non-pharmaceutical products such as health care products, medical supplies and medical devices are more popular. Data shows that in the first half of 2020, the company’s non-pharmaceutical product sales accounted for 71% of Jingdong Health’s total merchandise revenue.
Jingdong Group, as the head domestic integrated e-commerce company, has a large number of users, and with its close relationship with Jingdong Group, Jingdong Health can reach over 400 million active users. For the twelve months ended September 30, 2020, Jingdong Health had 80 million annual active users, nearly doubling that number compared to 2017.
Recent Comments